Evidence map›Paper›PMID 29512002›Full record

ArticleJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract2018

Hepatic Artery Resection for Bismuth Type III and IV Hilar Cholangiocarcinoma: Is Reconstruction Always Required?

Hai-Jie Hu, Yan-Wen Jin, Rong-Xing Zhou, Anuj Shrestha, Wen-Jie Ma, Qin Yang, Jun-Ke Wang, Fei Liu, Nan-Sheng Cheng, Fu-Yu Li

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Impact of Combined Vascular Resection and Reconstruction in Patients with Advanced Perihilar Cholangiocarcinoma.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2021
    Article
  8. Review
  9. Review
  10. Article
  11. External validation study of the 8Journal of gastrointestinal oncology · 2021
    Article
  12. Review
  13. Surgical Outcomes for Perihilar Cholangiocarcinoma with Vascular Invasion.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hai-Jie HuDepartment of Biliary Surgery, West China Hospital of Sichuan University, Chengdu, Sichuan Province, 610041, China.
Yan-Wen JinDepartment of Biliary Surgery, West China Hospital of Sichuan University, Chengdu, Sichuan Province, 610041, China.
Rong-Xing ZhouDepartment of Biliary Surgery, West China Hospital of Sichuan University, Chengdu, Sichuan Province, 610041, China.
Anuj ShresthaDepartment of Biliary Surgery, West China Hospital of Sichuan University, Chengdu, Sichuan Province, 610041, China.
Wen-Jie MaDepartment of Biliary Surgery, West China Hospital of Sichuan University, Chengdu, Sichuan Province, 610041, China.
Qin YangDepartment of Biliary Surgery, West China Hospital of Sichuan University, Chengdu, Sichuan Province, 610041, China.
Jun-Ke WangDepartment of Biliary Surgery, West China Hospital of Sichuan University, Chengdu, Sichuan Province, 610041, China.
Fei LiuDepartment of Biliary Surgery, West China Hospital of Sichuan University, Chengdu, Sichuan Province, 610041, China.
Nan-Sheng ChengDepartment of Biliary Surgery, West China Hospital of Sichuan University, Chengdu, Sichuan Province, 610041, China.
Fu-Yu LiDepartment of Biliary Surgery, West China Hospital of Sichuan University, Chengdu, Sichuan Province, 610041, China. lfy_74@hotmail.com.ORCID 0000-0003-2755-2887

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe objective of the study is to examine the feasibility of hepatic artery resection (HAR) without subsequent reconstruction (RCS) in specified patients of Bismuth type III and IV hilar cholangiocarcinoma.

methodsWe retrospectively reviewed 63 patients who underwent hepatic artery resection for Bismuth type III and IV hilar cholangiocarcinoma. These patients were subsequently enrolled into two groups based on whether the artery reconstruction was conducted. Postoperative morbidity and mortality, and long-term survival outcome were compared between the two groups.

resultsThere were 29 patients in HAR group and 34 patients in the HAR + RCS group. Patients with hepatic artery reconstruction tended to have longer operative time (545.6 ± 143.1 min vs. 656.3 ± 192.8 min; P = 0.013) and smaller tumor size (3.0 ± 1.1 cm vs. 2.5 ± 0.9 cm; P = 0.036). The R0 resection margin was comparable between the HAR group and HAR + RCS group (86.2 vs. 85.3%; P > 0.05). Twelve patients (41.4%) with 24 complications in HAR group and 13 patients (38.2%) with 25 complications in HAR + RCS group were recorded (P = 0.799). The postoperative hepatic failure rate (13.8 vs. 5.9%) and postoperative mortality rate (3.4% vs. 2.9%) were also comparable between the two groups. In the HAR group, the overall 1-, 3-, and 5-year survival rates were 72, 41, and 19%, respectively; while in the HAR + RCS group, the overall 1-, 3-, and 5-year survival rates were 79, 45, and 25%, respectively (P = 0.928).

conclusionsHepatic artery resection without reconstruction is also a safe and feasible surgical procedure for highly selected cases of Bismuth type III and IV hilar cholangiocarcinoma.

Indexed as

Bile Duct NeoplasmsFemaleHepatectomyHepatic ArteryHumansKlatskin TumorMaleMiddle AgedOperative TimePatient SelectionRetrospective StudiesTreatment OutcomeVascular Surgical ProceduresBismuth type III and IVHepatic artery resectionHilar cholangiocarcinomaReconstruction

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.